Wieck A
Baillieres Clin Obstet Gynaecol. 1989 Dec;3(4):857-77. doi: 10.1016/s0950-3552(89)80069-0.
Biological research in postnatal mental illness has only a short history and few encouraging data have yet emerged. The most promising positive findings are perhaps preliminary evidence for an increase of postnatal depression in women with postpartum thyroid dysfunction, some evidence for an enhanced sensitivity to changes in progesterone levels in postnatal depression, and the presence of an opioid peptide with unknown function in the cerebrospinal fluid of women with puerperal psychosis. Although steroid hormones are generally thought to be aetiologically relevant since they freely enter the brain and are known to interact with central monoamine neurotransmitter systems, attempts to demonstrate abnormal levels in postnatal disorders have been disappointing. An important reason for this outcome may be the usually employed approach of isolated hormone measurements. Ovarian steroid levels show marked interindividual variations. Thus significant between-group differences may only be obtained when large numbers of subjects are tested. Since only the unbound fraction can enter the brain, its measurement should be included in such studies. In the case of cortisol, single values are insufficient because of the pulsatile nature and the circadian pattern of its release. Thus serial sampling over 24 hours is more appropriate to detect secretory abnormalities. Measurements of circulating peptides are difficult to interpret since the amount reaching the brain is at best small. What is needed here are estimations of peptides in the cerebrospinal fluid which, however, pose ethical problems. Another explanation for the dearth of consistent positive data may be that women with postnatal mental disorders react to normal postnatal changes differently to women who remain well after childbirth. There is already evidence that patients at high risk of puerperal manic-depressive illness develop a hypersensitivity of central D2 receptors which may be related to the effects of oestrogen withdrawal on the function of DA systems. Further investigations of central neurotransmitter function are needed. In many ways postnatal mental disorders provide a unique opportunity for psychosomatic research since their onset can almost be predicted and follows an event which is associated with changes in many physiological systems. Results of recent neuropharmacological and behavioural investigations into the central effects of steroid and peptide hormones provide the basis for a multitude of pathogenetic hypotheses to be tested in postnatal mental disorders and research in this area may see exciting times ahead.
产后精神疾病的生物学研究历史较短,目前尚未出现太多令人鼓舞的数据。最有希望的阳性发现可能是产后甲状腺功能障碍女性产后抑郁症增加的初步证据、产后抑郁症中对孕酮水平变化敏感性增强的一些证据,以及产褥期精神病女性脑脊液中存在一种功能未知的阿片肽。尽管类固醇激素通常被认为与病因相关,因为它们可自由进入大脑且已知与中枢单胺神经递质系统相互作用,但试图证明产后疾病中激素水平异常的研究结果却令人失望。这一结果的一个重要原因可能是通常采用的孤立激素测量方法。卵巢类固醇水平存在显著的个体差异。因此,只有在测试大量受试者时才能获得显著的组间差异。由于只有未结合部分才能进入大脑,此类研究应包括对其的测量。就皮质醇而言,单次测量值并不足够,因为其释放具有脉冲性质和昼夜节律模式。因此,24小时连续采样更适合检测分泌异常。循环肽的测量结果难以解释,因为到达大脑的量至多很少。这里需要的是脑脊液中肽的估计值,然而这会带来伦理问题。缺乏一致阳性数据的另一个解释可能是产后精神障碍女性对产后正常变化的反应与产后保持健康的女性不同。已有证据表明,产褥期躁狂抑郁症高风险患者中枢D2受体出现超敏反应,这可能与雌激素撤退对多巴胺系统功能的影响有关。需要进一步研究中枢神经递质功能。在很多方面,产后精神障碍为身心研究提供了独特的机会,因为其发病几乎可以预测,且发生在与许多生理系统变化相关的事件之后。近期对类固醇和肽类激素中枢作用的神经药理学和行为学研究结果为在产后精神障碍中测试多种发病机制假说提供了基础,该领域的研究可能会迎来令人兴奋的时期。